Literature DB >> 3529090

Molecular cloning and nucleotide sequence of a full-length cDNA for human alpha enolase.

A Giallongo, S Feo, R Moore, C M Croce, L C Showe.   

Abstract

We previously purified a 48-kDa protein (p48) that specifically reacts with an antiserum directed against the 12 carboxyl-terminal amino acids of the c-myc gene product. Using an antiserum directed against the purified p48, we have cloned a cDNA from a human expression library. This cDNA hybrid-selects an mRNA that translates to a 48-kDa protein that specifically reacts with anti-p48 serum. We have isolated a full-length cDNA that encodes p48 and spans 1755 bases. The coding region is 1299 bases long; 94 bases are 5' noncoding and 359 bases are 3' noncoding. The cDNA encodes a 433 amino acid protein that is 67% homologous to yeast enolase and 94% homologous to the rat non-neuronal enolase. The purified protein has been shown to have enolase activity and has been identified to be of the alpha type by isoenzyme analysis. The transcriptional regulation of enolase expression in response to mitogenic stimulation of peripheral blood lymphocytes and in response to heat shock is also discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3529090      PMCID: PMC386585          DOI: 10.1073/pnas.83.18.6741

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

Authors:  M Grunstein; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  Enolase: human tissue distribution and evidence for three different loci.

Authors:  S H Chen; E R Giblett
Journal:  Ann Hum Genet       Date:  1976-01       Impact factor: 1.670

3.  [Purification and characterization of phosphopyruvate hydratase (=enolase; EC 4.2.1.11) in erythrocytes of newborn and adults].

Authors:  I Witt; D Witz
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1970-10

4.  Isolation and partial characterization of a 48-kDa protein which is induced in normal lymphocytes upon mitogenic stimulation.

Authors:  A Giallongo; S Feo; L C Showe; C M Croce
Journal:  Biochem Biophys Res Commun       Date:  1986-02-13       Impact factor: 3.575

5.  On the nature of crossreactions observed with antibodies directed to defined epitopes.

Authors:  E A Nigg; G Walter; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

6.  Identification of clones that encode chicken tropomyosin by direct immunological screening of a cDNA expression library.

Authors:  D M Helfman; J R Feramisco; J C Fiddes; G P Thomas; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

7.  Identification of the c-myc oncogene product in normal and malignant B cells.

Authors:  A Giallongo; E Appella; R Ricciardi; G Rovera; C M Croce
Journal:  Science       Date:  1983-10-28       Impact factor: 47.728

8.  The amino acid sequence of yeast enolase.

Authors:  C C Chin; J M Brewer; F Wold
Journal:  J Biol Chem       Date:  1981-02-10       Impact factor: 5.157

9.  Inhibition of intractable nucleases with ribonucleoside--vanadyl complexes: isolation of messenger ribonucleic acid from resting lymphocytes.

Authors:  S L Berger; C S Birkenmeier
Journal:  Biochemistry       Date:  1979-11-13       Impact factor: 3.162

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  41 in total

1.  Heat shock protein-27 protects human bronchial epithelial cells against oxidative stress-mediated apoptosis: possible implication in asthma.

Authors:  Anna M Merendino; Catherine Paul; Antonio M Vignola; Maria A Costa; Mario Melis; Giuseppina Chiappara; V Izzo; J Bousquet; André-Patrick Arrigo
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

2.  Purification and characterization of immunoglobulin production stimulating factor-II beta derived from Namalwa cells.

Authors:  T Sugahara; H Nakajima; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  The isolation of transcription factors from lambda gt11 cDNA expression libraries: human steroid 5 alpha-reductase 1 has sequence-specific DNA binding activity.

Authors:  K Gaston; M Fried
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

4.  Externalized glycolytic enzymes are novel, conserved, and early biomarkers of apoptosis.

Authors:  David S Ucker; Mohit Raja Jain; Goutham Pattabiraman; Karol Palasiewicz; Raymond B Birge; Hong Li
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

5.  The primary structure of rabbit muscle enolase.

Authors:  C C Chin
Journal:  J Protein Chem       Date:  1990-08

6.  Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy (MN).

Authors:  H Wakui; H Imai; A Komatsuda; A B Miura
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

7.  Characterization of a maize cDNA that complements an enolase-deficient mutant of Escherichia coli.

Authors:  S K Lal; S Johnson; T Conway; P M Kelley
Journal:  Plant Mol Biol       Date:  1991-05       Impact factor: 4.076

8.  Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens.

Authors:  S Szala; Y Kasai; Z Steplewski; U Rodeck; H Koprowski; A J Linnenbach
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

9.  Molecular structure of the human muscle-specific enolase gene (ENO3).

Authors:  M Peshavaria; I N Day
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

Review 10.  Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.

Authors:  D Allan Butterfield; Miranda L Bader Lange
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.